Alembic gains USFDA final approval for Lamotrigine Extended-Release Tablets USP, 200 mg, 250 mg, and 300 mg Read more
Biocon Biologics refinances $ 1.1 bn long-term debt through USD bonds and new syndicated facility Read more
Gilead Sciences signs licencing agreements with six companies to manufacture, commercialise Lenacapavir Read more
Emcure Pharmaceuticals sets Asia record for largest heart-shaped structure on World Heart Day Read more
ARS Pharmaceuticals’ Neffy poised to disrupt epinephrine market as first needle-free nasal spray: GlobalData Read more